Current position:Product center > Cell lines > TAA > AMHR2
AMHR2
Background

        

AMHR2 (anti-Müllerian hormone receptor type 2) is a protein-coding gene. This gene encodes the receptor for anti-Müllerian hormone (AMH), which, in addition to testosterone, is involved in male sex differentiation. AMH and testosterone are produced by different cells in the testes and have distinct roles. Testosterone promotes the development of male reproductive organs, while the binding of AMH to its receptor prevents the Müllerian duct from developing into a uterus and fallopian tubes.


Diseases associated with AMHR2 include persistent Müllerian duct syndrome, type I and type II, as well as testicular disorders. Related pathways include ALK2 signaling events and PEDF-induced signaling. Gene ontology (GO) annotations associated with this gene involve transferase activity, transferase activity, transferring phosphorus-containing groups, and protein tyrosine kinase activity.

AMHR2-2.png

Products
AMHR2 Expression Cell Line
Cat. No. Product Stock
GM-C09685
Mouse_AMHR2 HEK-293 Cell Line
In-stock
GM-C09686
Rat_AMHR2 HEK-293 Cell Line
In-stock
GM-C09687
Cynomolgus_AMHR2 HEK-293 Cell Line
In-stock
GM-C11728
H_AMHR2 RKO Cell Line
In-stock
GM-C15629
H_AMHR2 CHO-K1 Cell Line
In-stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
Current position:Product Center > Cell lines > TAA > AMHR2
classify
AMHR2
Background

T cell immunotherapy typically targets two classes of antigens: private antigens and public antigens. Public antigens are those shared among multiple patients, with tumor-associated antigens (TAAs) being antigens that are highly expressed in tumor cells and present in healthy cells but at lower levels. 

Targeted therapy against TAAs is a crucial approach in cancer treatment, with several immunotherapy drugs relying on this mechanism proving to be very effective clinically. The development of drugs targeting TAAs remains an active area of research, with numerous targeted drugs for different types of tumors currently undergoing preclinical or clinical testing. Antibodies targeting TAAs can not only directly kill tumor cells through ADCC effects but also serve as diagnostic markers or innovative additions to traditional cancer therapies.TAA-2.png

Product List
AMHR2 Expression Cell Line
Cat. No. Product Stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
GM-C15537
H_AMHR2 MC38 Cell Line
In-stock
Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit